Track Mallinckrodt Plc - New's long-term debt ($2.5B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), MNK shows a long-term debt of $2.5B. That compares with $910M in the prior-year period — up 178.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MNK's long-term debt is now $2.5B (was $910M) — a 178.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Mallinckrodt Plc - New is outperforming or lagging.
Tracking MNK's long-term debt over time shows whether Mallinckrodt Plc - New is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5B That compares with $910M in the prior-year period — up 178.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Mallinckrodt Plc - New's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $2.5B) with ownership activity and broader fundamentals.
Mallinckrodt Plc - New's long-term debt is $2.5B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.